Green Cross Lab Cell Corporation Capital Reinvestment Ratio
Green Cross Lab Cell Corporation capital reinvestment ratio. Green Cross Lab Cell Corporation (144510) has a Capital Reinvestment Ratio of 13.65x as of June 2026, meaning it reinvests 14% of its operating cash flow (₩208.25 Million) in capital expenditures (₩2.84 Billion). See Green Cross Lab Cell Corporation free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Green Cross Lab Cell Corporation (2015–2025)
Capital reinvestment ratio of Green Cross Lab Cell Corporation from 2015 to 2025. This chart tracks Green Cross Lab Cell Corporation's Capital Reinvestment Ratio across 10 annual periods. See Green Cross Lab Cell Corporation financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Green Cross Lab Cell Corporation Capital Reinvestment Ratio by Year (2015–2025)
Green Cross Lab Cell Corporation capital reinvestment ratio by year from 2015 to 2025. For the full cash flow conversion analysis, see 144510 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.70x | ₩9.19 Billion | ₩6.47 Billion | ▲ +32.4% |
| 2024 | 0.53x | ₩11.34 Billion | ₩6.03 Billion | ▼ -89.4% |
| 2023 | 5.01x | ₩3.67 Billion | ₩18.40 Billion | ▲ +4713.9% |
| 2022 | 0.10x | ₩66.42 Billion | ₩6.91 Billion | ▼ -77.1% |
| 2021 | 0.45x | ₩23.91 Billion | ₩10.88 Billion | ▼ -13.6% |
| 2020 | 0.53x | ₩9.09 Billion | ₩4.79 Billion | ▼ -97.8% |
| 2019 | 23.96x | ₩223.04 Million | ₩5.34 Billion | ▲ +146.1% |
| 2018 | 9.74x | ₩490.92 Million | ₩4.78 Billion | ▲ +1468.4% |
| 2017 | 0.62x | ₩2.86 Billion | ₩1.78 Billion | ▲ +10.8% |
| 2015 | 0.56x | ₩1.49 Billion | ₩833.86 Million | — |